Three things to know:
1. Mount Sinai Hospital’s weaker performance is partly driven by higher permanent labor costs, according to Moody’s. Its liquidity will continue to be negatively affected by material transfers to support losses at affiliate hospitals and network expansion as well as a relatively high allocation to alternative investment strategies.
2. The “Baa1” is supported by the system’s high acuity services in a competitive market, which will support volume growth, Moody’s said.
3. Research, commercialization opportunities and fundraising at the Icahn School of Medicine at Mount Sinai will benefit the system while an accelerated improvement plan, Medicaid rate increases and completion of an IT platform will help improve operating performance.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
